Why are Canadian biotech firms having problems raising financing capital?
In 2001, Canadian biotech firms raised $980 million in financing capital, a sharp drop from the $2.1 billion raised in 1999. Overall, 114 firms out of 188 (61%) that attempted to raise capital either failed or did not reach their targets. Why are biotech firms encountering difficulties in raising financing capital?
| Format | Release date | More information |
|---|---|---|
| June 27, 2003 |